ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage

July 18, 2014

In Brief: Reginald Ho Assumes ACS Presidency; Board Calls On NCI To Fully Fund ASSIST Program

November 13, 1992

In Brief: Freireich On Nutrition: Diet Can Affect Immune System, Effectiveness Of Cancer Drugs

September 12, 1975

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996